Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Elanco Animal Health Inc (NY: ELAN )

14.37 -0.15 (-1.03%)
Official Closing Price Updated: 7:00 PM EDT, Oct 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Elanco Animal Health Inc

< Previous 1 2 3 4 Next >
ELAN INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Elanco Animal Health Incorporated Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
ROSEN, A LEADING LAW FIRM, Encourages Elanco Animal Health Incorporated Investors to Secure Counsel Before Important Deadline in Securities Class Action – ELAN
From The Rosen Law Firm PA
Via GlobeNewswire
Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Elanco Animal Health Incorporated (ELAN) Investors
From Kirby McInerney LLP
Via Business Wire
ELANCO ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Elanco Animal Health Incorporated and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Investor Notice: Robbins LLP Informs Stockholders of the Class Action Lawsuit Filed Against Elanco Animal Health Incorporated
From Robbins LLP
Via GlobeNewswire
ELAN Investors Have Opportunity to Lead Elanco Animal Health Incorporated Securities Fraud Lawsuit with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
Rosen Law Firm Urges Elanco Animal Health Incorporated (NYSE: ELAN) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
From Rosen Law Firm
Via Business Wire
ELANCO ANIMAL HEALTH INCORPORATED (NYSE: ELAN) INVESTOR ALERT: Investors With Large Losses in Elanco Animal Health Incorporated Should Contact Bernstein Liebhard LLP To Discuss Their Rights
From Bernstein Liebhard LLP
Via GlobeNewswire
ELAN Investors Have Opportunity to Join Elanco Animal Health Incorporated Securities Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
Elanco Animal Health Incorporated (ELAN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
ELAN Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Elanco Animal Health Incorporated (NYSE: ELAN) Investors with Significant Losses to Contact the Firm
From Kessler Topaz Meltzer & Check, LLP
Via Business Wire
ELANCO ALERT: Bragar Eagel & Squire, P.C. is Investigating Elanco Animal Health Incorporated on Behalf of Elanco Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Elanco Animal Health Incorporated (ELAN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Ancora Nominates Four Highly Qualified, Independent Director Candidates and Urges Orderly CEO Succession at Elanco Animal Health
From Ancora Holdings Group, LLC
Via Business Wire
Merck Animal Health to Acquire Elanco’s Aqua Business
From Merck & Co., Inc.
Via Business Wire
Elanco to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
From Elanco Animal Health Incorporated
Via Business Wire
Elanco to Participate in Evercore ISI 6th Annual HealthCONx Conference
From Elanco Animal Health Incorporated
Via Business Wire
Elanco Animal Health Reports Third Quarter 2023 Results
From Elanco Animal Health Incorporated
Via Business Wire
Athian and Elanco Animal Health Team Up to Transform Food Production through Methane Reduction
From Elanco Animal Health Incorporated
Via Business Wire
Elanco Confirms Date and Conference Call for Third Quarter 2023 Financial Results Announcement
From Elanco Animal Health Incorporated
Via Business Wire
Elanco Announces Corporate Governance Enhancements
From Elanco Animal Health Incorporated
Via Business Wire
Elanco Launches Varenzin™-CA1 (molidustat oral suspension) – the First-of-its-Kind Oral Treatment for Anemia in Cats with Chronic Kidney Disease
From Elanco Animal Health Incorporated
Via Business Wire
Elanco to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
From Elanco Animal Health Incorporated
Via Business Wire
Elanco Animal Health Reports Second Quarter 2023 Results and Raises Full Year Guidance
From Elanco Animal Health Incorporated
Via Business Wire
Elanco Releases 2022 Environmental, Social and Governance Report, Demonstrating Sustainability Progress in Internal Operations and Customer Collaborations
From Elanco Animal Health Incorporated
Via Business Wire
Elanco Confirms Date and Conference Call for Second Quarter 2023 Financial Results Announcement
From Elanco Animal Health Incorporated
Via Business Wire
Environmental Protection Agency (EPA) Completes Review of Seresto® Collar and Confirms Continued Registration; Data Affirms Safety Profile of the Product
From Elanco Animal Health Incorporated
Via Business Wire
Bullish or Bearish? Vetting Animal Health Care Stocks
Americans are paying more and more attention to pet health, making pet care stocks look healthy again. Here are two names worth a check up. 
Via MarketBeat
Topics ETFs
Elanco to Participate in Goldman Sachs 44th Annual Global Healthcare Conference
From Elanco Animal Health Incorporated
Via Business Wire
Elanco to Participate in Stifel 2023 Jaws and Paws Conference
From Elanco Animal Health Incorporated
Via Business Wire
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.